Methylation in Prostate Cancer Blood Vessel Cells
Author Information
Author(s): Amelia C Grover, Michael A Tangrea, Karen G Woodson, Benjamin S Wallis, Jeffrey C Hanson, Rodrigo F Chuaqui, John W Gillespie, Heidi S Erickson, Robert F Bonner, Thomas J Pohida, Michael R Emmert-Buck, Steven K Libutti
Primary Institution: National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Hypothesis
Do tumor-associated endothelial cells exhibit similar methylation changes as tumor epithelial cells in prostate cancer?
Conclusion
The study found significant methylation of GSTP1 and RARβ2 in tumor-associated endothelial cells, suggesting epigenetic changes may influence tumor vasculature.
Supporting Evidence
- 100% methylation of GSTP1 was found in tumor-associated endothelium.
- 88% methylation of RARβ2 was detected in tumor areas.
- No methylation was observed in normal tissue for either gene.
Takeaway
The researchers looked at blood vessel cells in prostate cancer and found that they have similar changes in their DNA as the cancer cells, which might help us understand how tumors grow.
Methodology
Endothelial cells were isolated from prostate tissue using Expression Microdissection and analyzed for methylation status of GSTP1 and RARβ2 using QMS-PCR.
Potential Biases
The study may have bias due to the small sample size and the possibility of contamination during dissection.
Limitations
Potential contamination of endothelial samples with tumor epithelial cells could affect methylation results.
Participant Demographics
Patients with clinically localized prostate cancer who underwent radical prostatectomy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website